HTG Molecular Diagnostics, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for HTG Molecular Diagnostics, Inc. (HTGM) is 1.89

According to HTG Molecular Diagnostics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.89. This represents a change of 11.73% compared to the average of 1.69 of the last 4 quarters.

HTG Molecular Diagnostics, Inc. (HTGM) Historical Current Ratio (quarterly & annually)

How has HTGM Current Ratio performed in the past?

The mean historical Current Ratio of HTG Molecular Diagnostics, Inc. over the last ten years is 3.09. The current 1.89 Current Ratio has changed 6.03% with respect to the historical average. Over the past ten years (40 quarters), HTGM's Current Ratio was at its highest in in the March 2018 quarter at 9.79. The Current Ratio was at its lowest in in the June 2013 quarter at 0.

HTG Molecular Diagnostics, Inc. (HTGM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of HTG Molecular Diagnostics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HTG Molecular Diagnostics, Inc. (HTGM) Average Current Ratio

How has HTGM Current Ratio performed in the past?

The current Current Ratio of HTG Molecular Diagnostics, Inc. (HTGM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

HTG Molecular Diagnostics, Inc. (HTGM) Current Ratio vs. Peers

How is HTGM’s Current Ratio compared to its peers?

HTG Molecular Diagnostics, Inc.’s Current Ratio is less than 9 Meters Biopharma, Inc. (0), less than Impel Pharmaceuticals Inc. (3.60), greater than Accelerate Diagnostics, Inc. (0.71), less than InVivo Therapeutics Holdings Corporation (7.13), greater than Lucy Scientific Discovery Inc. (1.41), greater than Altamira Therapeutics Ltd. (1.32), greater than Neptune Wellness Solutions Inc. (1.23), less than CohBar, Inc. (15.69), less than Timber Pharmaceuticals, Inc. (1.95), greater than Acorda Therapeutics, Inc. (0.33),

Build a custom stock screener for HTG Molecular Diagnostics, Inc. (HTGM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HTG Molecular Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HTG Molecular Diagnostics, Inc. (HTGM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HTG Molecular Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.